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Abstract 
Regular ingestion of American cranberry (Vaccinium macrocarpon) has been 
traditionally utilized for its health benefits against urinary tract infections. The proanthocyanidins 
(PACs), in particular, the unique A-type double linkages of PACs present in cranberry, have 
been identified as the active components. However, A-type PACs and any other active agents 
have not yet been detected or identified in urine. Additional experiments are required to 
investigate the inhibitory effects and persistence of cranberry metabolites present in urine 
collected following CJC consumption, and to determine how these compounds act against 
uropathogenic Escherichia coli for the prevention of urinary tract infections.  
Two separate bioassays (a biofilm formation assay and a bacterial cell viability assay) 
were used to determine the in vitro effect of cranberry juice cocktail (CJC) oral consumption on 
bacterial anti-adhesion activity in a double-blind, placebo-controlled pilot clinical trial. A single 
dose of 16 oz. of CJC or a placebo beverage was given to ten healthy women, ages ranging from 
18 to 27, and urine samples were collected in the following 48 hours. A washout period of seven 
days was allowed. Bacteria (Escherichia coli B37, CFT073, BF1023, HB101, and 
Staphylococcus aureus ATCC43866) were cultured in the urine samples, supplemented with 
media, and the amount of biofilm formed was measured using a crystal violet absorbance assay 
in a 96-well plate. In the urine of volunteers who had consumed CJC, biofilm formation was 
inhibited within 24 hours after CJC consumption, and started to increase after 48 hours by 49-
67%. S. aureus showed the least biofilm formation after incubation with post-CJC urine. The 
results indicated that drinking CJC can be an effective preventive measure for bacterial adhesion 
and biofilm formation in healthy women. The anti-biofilm activity peaks between 24 and 48 
hours after drinking CJC. The viability assay showed that the colony count after culturing in 
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urine collected following consumption of CJC or placebo were not significantly different, 
implying that CJC works as an inhibitor by blocking bacterial adhesion instead of killing the 
bacteria or restraining its growth.  
Another randomized, placebo-controlled, double-blind, crossover study was conducted to 
further investigate the molecular-scale effect of cranberry juice metabolites on two P-fimbriated 
E. coli strains: B37 and CFT 073, as assessed by atomic force microscopy (AFM). Three female 
subjects were asked to consume 8 oz. CJC or water. The washout period was 7 days. The urine 
samples were collected at 2, 4 and 6 hours post-ingestion of CJC or water. Urine collected before 
consumption of CJC was used as a control. For this control urine, the average adhesion force 
between E. coli and uroepithelial cells was 13.09 ± 11.60 nN for CFT073 and 10.30 ± 5.50 nN 
for B37. For post-CJC urine treatment, the adhesion forces decreased to 2.94 ± 1.82 nN at 2 
hours after consumption then increased slightly to 5.51 ± 2.78 nN at 6 hours after ingestion for 
CFT073, while they decreased to 4.77 ± 3.33 nN after consuming for 2 hours and seemed to be 
stable in the next 4 hours following consumption (5.52 ± 4.04 nN after drinking for 4 hours; 5.05 
± 4.42 nN after drinking for 6 hours) for B37. The adhesion forces in post-water consumption 
urine were similar to those of the background for E. coli B37; meanwhile a downward trend for 
the adhesion forces in post-water consumption urine compared to the background was observed 
for E. coli CFT073. However, these adhesion forces in post-water consumption urine were still 
higher than those measured after CJC consumption at the same time intervals. The mean 
differences between the cranberry and placebo groups were statistically different according to the 
two way ANOVA procedure followed by Holm-Sidak test. Our results suggest a significant 
inhibitory interaction between the daily consumption of 8 oz. cranberry juice and bacterial 
adhesive activity.  
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These results help form the mechanistic understanding of how cranberry products can be 
used to prevent bacterial attachment to host tissue, and may lead to new therapeutic strategies to 
prevent the rising problem of bacteria antibiotic resistance.   
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Chapter I: Research Motivation 
Urinary Tract Infections (UTIs) are among one of the most common bacterial infections 
affecting humans. It has been estimated that one out of three women experience a UTI at least 
once in her lifetime [1]. The cost of direct and indirect treatment exceeds two billion dollars per 
year [2]. Bacteria, especially gram-negative Escherichia coli (E. coli), are the most predominant 
cause of UTIs [3]. Due to the lack of knowledge of effective dose for the antibiotics to treat UTIs 
and the increasing concern of antibiotic-resistant bacteria [4], alternative therapies to prevent and 
treat UTIs are needed.  
American cranberry (Vaccinium macrocarpon), a native fruit to North America, has a 
long history of use to prevent UTIs [5-9] and is utilized widely to maintain urinary tract health. 
However, the active components and molecular mechanism of cranberry’s actions are still not 
well documented. Its natural high acid content was thought to be responsible for its health 
benefits for generations [10-12]. However, this theory was disproved by later studies [13, 14]. 
Researchers today focus on the anti-adhesion mechanism, with the predominant theory being that 
cranberry juice inhibits bacteria from attaching to uroepithelial cells, interfering with the 
important initial step in the development of an infection [15, 16]. Recently, A-type 
proanthocyanidins (PACs) present in cranberry were identified as the agents that cause this anti-
adhesive effect [17, 18]. However, there are few reported studies addressing whether the active 
compounds can survive in the digestive system. Furthermore, whether A-type PACs eliminate 
the colonization of uropathogenic E. coli known as biofilm or whether they act on uroepithelium 
directly remains unclear. This study was designed to address these questions. We believe that 
these results could help understand how cranberry products can be used to prevent bacterial 
Chapter I: Research Motivation 
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attachment to host tissue, and may lead to the development of better therapies for the prevention 
of UTIs. 
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Chapter II Literature Review 
2.1 Urinary Tract Infections 
The function of the urinary system, including the urethra, bladder, ureters, and kidney, is 
to maintain proper water and salt balance throughout the body. Healthy urine is generally sterile 
even though it contains a variety of fluids, salts, and waste products. When a bacterium invades 
one or more parts of the urinary system, grows and multiplies, the infections develop. UTI is 
defined as the presence of bacteria in the urinary tract system [19]. 
 
Figure 2.1 Cumulative probability of self-reported physician-diagnosed urinary tract infection by age 
among 2000 women in the United States participating in a random digit dialing survey [1] 
UTIs account for 80% of all bacterial infections affecting humans today, and are 
especially prevalent in females since they have shortened urethra [8] compared to males. It is 
estimated that about 60% of healthy women suffer symptoms of UTI [2] at sometime in their life 
Chapter II: Literature Review 
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and many will experience them several times, with a significant incidence increase (Figure 2.1) 
related to age [1, 9, 20]. The management of UTIs accounts for over 9.6 million office visits to 
physicians annually, with the cost per visit nearly $100 [21].  
2.1.1 Acute Cystitis and Pyelonephritis 
A UTI can occur either from the bottom of the urinary tract systems or from the upper 
part. If bacteria multiply at the opening of the urethra and travel up to the bladder, acute cystitis 
(bladder infection) can develop, which is the most common type of UTI. A more serious 
condition is pyelonephritis (kidney infection), caused by bacteria spreading from the bloodstream 
to the kidney. Cystitis has a high recurrence rate [22]. Urine is generally a good culture medium 
for bacteria, and this can trigger a recurrent infection [23]. 
2.1.2 Pathogenesis and Virulent Factors 
Since a healthy urinary system is generally sterile, bacterial entry and proliferation is a 
must for UTIs to occur [7]. They can be caused by any number of bacteria but are most often 
brought on gram-negative bacteria, especially Escherichia coli (E. coli). 
3
Uropathogenic strains of 
E. coli account for 85-95% of cystitis cases and 90% of acute pyelonephritis infections [ , 8], 
while Staphylococcus saprophyticus is the cause in 5-10%. 
Bacterial adherence to mucosal cells has been considered as a critical step in the 
development of infection. 
E. coli is normally present in the 
intestines and can spread by, entering through the opening of the urethra where urine is excreted. 
Most of the time, the immune system eliminates E. coli that colonizes in the wrong areas of the 
body. However, when this mechanism fails, E. coli can grow, multiply, travel up the urinary 
system, and cause infection in the form of cystisis, and possibly reaching your kidneys. 
E.coli adhesins, the fimbrial structures, which aid bacteria to adhere to 
Chapter II: Literature Review 
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the surface of the urinary epithelium [6] have been studied, especially type I pili [24] and P 
fimbriae [25]. Type I pili mediate bacteria to adhere to mannose-specific receptors on urinary 
epithelium and are expressed in almost every uropathogenic E. coli isolate [26]. Their presence 
at the bacterial surface between isolates causing cystitis or pyelonephritis is the same [27]. 
2.1.3 Treatment and Problems 
P 
fimbriae, which have a terminal receptor for the ‘P’ antigen [8] (a blood group marker), not only 
binds to red cells, but also helps bacterial adhesion to the disaccharide alpha-D-Gal(1-4)-beta-D-
Gal specific receptors [28], resulting in a biofilm on the surface of the urinary epithelium and 
catheter [26].  
Although UTI is considered a minor illness, it may cause severe discomfort [8]. If the 
bacteria have inflamed the kidneys and bladder, the patient may feel pain in the lower back or 
pelvis. However, they are also easy to treat and prevent with a course of antibiotics which are 
commonly used.  
Although antibiotics are used routinely for treatment of UTIs, knowledge of the dose is 
still not well documented. Hence, these agents are not always effective. Overtreatment can cause 
such side effects sometimes as nausea, diarrhea, Candidal infections or even poses a threat of 
complications. Certain groups, especially women, are more prone to repeated infections. 
Recurrences frustrate the patient and may contribute to the development of bacterial antibiotic 
resistance. It has been suggested that uropathogens (e.g. 15-20 % or more of E. coli strains) are 
continuously resistant to antibiotics in the United States [4] and worldwide. In the case of kidney 
infection, the patient may require a hospital stay and intravenous antibiotics to treat. Due to the 
need to supplement bactericidal therapeutic strategies, alternative therapies that inhibit bacterial 
adhesion processes are increasingly important. Consumption of American cranberry (Vaccinium 
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macrocarpon) has been utilized for prevention of urinary tract infections for decades [7, 8, 15, 21, 
29, 30].  
2.2 Biofilms 
A biofilm is defined as a matrix-enclosed bacterial population adherent to a surface or 
interface [31]. Biofilms are common in nature and they can be regarded as a crucial survival 
mechanism that hinders the eradication of bacteria [32] from the environment.  
2.2.1 Development of Biofilms 
A biofilm is a complex polymer aggregate of microorganisms growing on surface (Figure 
2.2). Initially the free-floating microorganisms attach to the surface by weak van der Waals 
forces, which are reversible. The attached microorganism could be easily separated from the 
surface and immediately washed away by fluids. If it does not, the microorganism can use its 
specific cell adhesion molecules such as pili to anchor themselves to the surface permanently. 
Bacteria living in the biofilm can exhibit significantly different properties from free-floating 
bacteria due to the different patterns of gene expression [33]. At a higher level of organization, 
the dense extracellular matrix and the outer layer of cells could help protect the bacteria inside 
the film to withstand phagocytic cells and host immune responses. Also, the bacteria within 
biofilms have increased resistance to detergents and antibiotics compared to the non-attached 
planktonic ones. For this reason, the antimicrobial may only kill the bacteria in the outer layers 
of the biofilm, allowing the healthy bacteria within it to regrow rapidly. Beyond that, repeated 
use of antimicrobial agents can cause bacteria to develop resistance [4].  
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2.2.2 Biofilms and Infectious Diseases 
Biofilms are very commonly found on most wet surfaces in nature and can cause severe 
environmental problems. Humans have suffered from acute bacterial infections for many 
centuries; various ways are developed to treat the microbial infections. However, infection 
threats due to organisms present in biofilms remain an issue.  
Biofilms are associated with a wide variety of microbial infections in the body, including 
UTIs [23, 34], catheter infections [35], formation of dental plaque [36], gingivitis [37] and 
infections on contact lenses [38]. Biofilms can also be found on the inert surfaces of implanted 
devices such as catheters, prosthetic cardiac valves, and intrauterine devices [39].  
1. initial attachment  
2. irreversible attachment  
3. maturation I  
4. maturation II  
5. dispersion 
 
Figure 2.2 Schematic of Phase of Biofilm Formation Development 
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2.2.3 Biofilms and UTIs 
During cystitis, uropathogenic E. coli invade the healthy epithelial cells and rapidly 
increase in numbers to form biofilms. Under the protection of biofilm, the bacteria are more 
resistant to immune-system attacks and antibiotic treatments, and are more firmly anchored in 
infected cells. This is often the cause of chronic UTIs [23]. 
Protective mechanisms that interfere with bacterial adhesion in the urinary tract have not 
been completely elucidated. However, it has been proposed that ingestion of an adhesion-
interfering substance may impair bacterial infection capability [16, 21, 40]. 
2.3 Impact of Natural Products on Infections 
Numerous studies have indicated that dietary consumption of fruits and vegetables 
reduces the risk of many chronic diseases such as cardiovascular disease and cancers [41-43]. 
They are rich in micronutrients such as carotenoids, vitamins C and E, folic acid, flavonoids, 
phenols, isothiocyanates, and fiber, which might be a potential reason for the health effects. 
Hence, extracts of vegetables and fruits are often used as a compound of functional foods, 
dietary foods or dietary supplements. As a part of human diet all over the world, the beneficial 
effects of berries have attracted a great attention for research interests, especially cranberry 
(Vaccinium fruit).  
2.3.1 Cranberry Constituents and Infections 
The American cranberry (Vaccinium macrocarpon), a native member of the North 
American fruit family, is composed of water (80-88%) and carbohydrates (10%) [44]. The 
remaining 10% is made up of flavonoids, anthocyanins, catechin, triterpenoids, organic acids and 
ascorbic acid [30].  Because this fruit is rich in vitamin C, dietary fiber and the essential dietary 
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mineral, manganese, it has been widely used in a variety of food products including juices and 
sauces. Cranberry was ranked the fifth highest selling herb in the US and sales of cranberry have 
shown continued growth for years, exceeding $15 million in 2005 [45]. The fresh cranberry has a 
high content of acid and is astringent for consuming directly. A sweetened drink, cranberry juice 
cocktail which contains ~27% cranberry juice, sweetener, water and added vitamin C was 
introduced.  
The health benefits of the American cranberry (fruits and leaves) have been of interest for 
generations. Some researchers are exploring the cranberry’s effects on heart disease [46, 47], 
yeast infections and other conditions, and other researchers are investigating its potential against 
cancer [46, 48]. No major adverse effects or interactions were reported or identified in recent 
studies [49, 50]. Drinking cranberry juice regularly is a promising method to reduce or eliminate 
UTIs. 
2.3.2 Cranberry and UTIs 
Clinical studies showed a significant role of cranberry in maintaining urinary tract health, 
but the molecular mechanism is still unclear. It has been proposed that cranberry contains two 
components, fructose and a specific A-type PACs [16], both of them could inhibit the pathogenic 
bacteria from binding to the uroepithelium cells, which is the first step of the infection. Further 
research is required to clarify unanswered questions regarding the role of cranberries in 
protecting against UTI in general.  
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2.3.3 Mechanism of Cranberry Juice Health Benefits on UTIs 
2.3.3.1 Urinary Acidification 
Factors that do not favor bacterial growth include a low pH (5.5 or less) and a high urea 
concentration [8]. The latter varies due to individual conditions and dietary habits. In 1923, 
Blatherwick and Long [10] proposed that the cranberries’ naturally high acid content could 
enhance acidification of the urine, producing an antibacterial effect in the body. Furthermore, 
Kinney et al. [11] and in Jackson et al. [12] showed that cranberry juice can lower urinary pH. 
However, the quantities of cranberry juice required to cause a pH change were much higher than 
that generally consumed. Later, Nickey [13] and Avorn et al. [14] demonstrated that regular 
consumption of cranberry juice reduced the presence of bacteria in the urine, but this effect was 
not related to more acidic urine, indicating that increased urinary acidification does not appear to 
have a significant role in cranberry’s effect in maintaining urinary tract health.  
2.3.3.2 Anti-adhesion Effect on Pathogenic E. coli  
Recent research [13, 14] suggested that acidification of urine was not the reason for the 
anti-bacterial properties of cranberry juice.  In 1984, Sobota [15] proposed a more likely 
potential mechanism, which is that the preventative effect is achieved by inhibiting bacteria from 
adhering to uroepithelial cells. Later, Zafriri et al. [16] found that this benefit is due to two 
components in cranberry. Fructose, a constituent of many fruit juices including cranberry juice, 
orange juice, and pineapple juice, has been implicated as an important indicator of type I pili 
(mannose-sensitive) mediated adherence [16]. Proanthocyanidins (PACs), uniquely present in 
cranberries, have been demonstrated to inhibit type P pili (mannose-resistant) mediated 
adherence irreversibly [16, 51].  
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Figure 2.3 Molecular structure of A-type PACs [17] 
Foo et al. and Howell et al. [17, 18] identified that the unique PACs with special A-type 
double linkages, which refer to the double bonds between the epicatehin/catechin units in PACs 
molecules (Figure 2.3), may be responsible for the anti-adhesion process. Ofek et al. [52] 
supported this hypothesis by showing that no anti-adhesion activities were observed after 
consuming other food sources of PACs that only contain common B-type linkages which are 
single bonds, including chocolate, grape, apple and green tea.  
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2.4 Atomic Force Microscope   
Biofilm assay is an effective way to demonstrate bacterial adhesion activity, but other 
techniques are needed to directly and quantitatively detect cranberry juice cocktail’s anti-
adhesive ability.  
 
 
Figure 2.4 Schematic of AFM operating principles [53] 
The atomic force microscopy (AFM) is a sensitive tool for measuring forces (in the pico- 
to nano-Newton range) as a function of separation distance. A flexible cantilever with a sharp tip, 
which may either be an inert material such as silicon or silicon nitride or can be functionalized 
with a bacterial cell, is operated as a probe of a sample surface and bends in response to surface 
forces. These deflections are detected by monitoring the position of a laser focused on the tip, 
through a four-quadrant photodiode detector (Figure 2.4). This signal is recorded and used to 
adjust the feedback loop. The adjusted voltage then applied to a piezo to control the movement 
of the tip further in order to bring it alternately into contact with the sample surface. 
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2.4.1 Direct Force Measurements Using Atomic Force Microscopy 
 
Figure 2.5 Forces are measured during the approach (upper, red line) and retraction (lower, purple line) 
of the probe with the sample. The “approach” curve describes the interfacial forces acting between the 
bacterial probe and uroepithelial cells. The “retraction” curve represents the adhesive forces that hold the 
two together after contact has been made.  
 
Using AFM, forces can be easily measured both during the approach of the probe to the 
sample (red arrow in Figure 2.5), as well as during the retraction of the probe from the sample 
after contact has been made (purple arrow in Figure 2.5). The approach of the AFM profiles 
reflect the interaction forces between the probe and sample, which is generally repulsive (red 
curve showing F>0 in Figure 2.5). Retraction profiles provide information on adhesion forces 
(purple peak showing F<0 in Figure 2.5) between the probe and tip. By directly detecting such 
interactions, we can determine the mechanism controlling the adhesion of E. coli to uroepithelial 
cells in occurrences of UTIs. The adhesion between a biological functionalized probe, where an 
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E. coli bacterium is coated to the probe and uroepithelial cell surfaces will be therefore 
quantified in this study. This technique represents a more rapid way to quickly screen among 
different treatments, such as comparing the behavior of multiple solutions or various bacterial 
isolates. 
The tip used for the force measurements is calibrated individually before use in order to 
obtain the cantilever spring constant (k). Once the spring constant is known, the force (F) as a 
function of separation distance between the sample and tip (x) can be calculated from Hooke’s 
Law for linear and elastic springs, which states that  
F = kx                Equation 2.1 
2.5 Preliminary Studies of Bacterial Attachment in Our Lab 
Using biofilm assay and AFM technique, the preventive effects of cranberry on urinary 
tract infections has been clinically evaluated in many products, including cranberry juice 
concentrate [54], cranberry juice cocktail [14] and  cranberry capsules [55]. Cranberry products 
that have been studied in our lab were mainly cranberry juice cocktail [56-59] or isolated 
proanthocyanidins (PACs) [60] in previous studies.  
2.5.1 Cranberry Juice on Physicochemical Surface Characteristics and Adhesion 
Behavior of Escherichia coli  
In order to better understand the mechanism associated with the molecular-scale effects 
of cranberry juice cocktail on physicochemical surface properties of E. coli, experiments [57] 
were conducted to investigate both bacterial surface characteristics and adhesion forces between 
a probe surface (silicon nitride) and the bacteria after a short exposure period (<3 h) via AFM. 
Two E. coli strains: HB101, which has no fimbriae, and the mutant HB101pDC1 which 
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expresses P-fimbriae were tested. The results showed that cranberry juice could affect the P-
fimbriated bacteria by altering the conformation of the surface macromolecules on E. coli 
HB101pDC1, which decreased the adhesion forces between the treated bacterium and the AFM 
tip.  
Furthermore, a thermodynamic approach was used in our lab [59] to calculate the 
changes in the Gibbs free energy change of adhesion changes (ΔGadh) for bacteria-uroepithelial 
cell (UC) interactions. E. coli HB101pDC1 (P-fimbriated) and HB101 (non-fimbriated) were 
exposed to cranberry juice at different concentrations (0–27 wt %). For HB101 interacting with 
UC, ΔGadh was always negative and the values were insensitive to cranberry juice concentration. 
For the HB101pDC1-UC system, which could form strong bonds with the Gal–Gal disaccharide 
receptor on uroepithelial cells, ΔGadh
2.5.2 Anti-adhesive Effects of Cranberry Juice Cocktail vs. Isolated PACs 
 became positive at 27 wt % cranberry juice, indicating that 
adhesion was unfavorable. The results suggested that cranberry juice may disrupt bacterial 
ligand-UC receptor binding. 
In order to better answer questions regarding whether PACs are the main or the only 
active components in CJC, our lab measured the adhesion forces between an AFM probe (silicon 
nitride) and individual E. coli cells grown in cranberry products [60]. P-fimbriated bacterial 
strain E. coli HB101pDC1, and the non-fimbriated E. coli HB101, were used. Bacteria were 
cultured in tryptic soy broth (TSB) supplemented with neutralized, light cranberry juice cocktail 
(L-CJC) from Ocean Spray Cranberries, Inc. or a solution of isolated cranberry juice 
proanthocyanidins (PACs) provided by Ocean Spray. The results showed that growth of E. coli 
HB101pDC1 and HB101 in L-CJC or PACs resulted in a decrease in adhesion forces with an 
increasing number of cultures, and the behavior was dose-dependent fashion. When the bacteria 
Chapter II: Literature Review 
- 16 - 
 
were exposed to increasing concentrations of L-CJC treatment (27% by weight) and PACs 
treatment (345.8 µg/mL), the adhesion forces further decreased. This effect was reversible.  
When bacteria were regrown in cranberry-free medium, they could regain their ability to attach 
to uroepithelial cells, and the adhesion forces reverted to the values of the control case.  
In addition, a biofilm formation assay was used to detect in vitro anti-adhesion activity of 
cranberry products such as CJC and isolated PACs. Briefly, bacteria were cultured in Luria-
Bertani media and mixed with CJC or PACs in PVC 96 well plates for 48 hrs. After incubation 
for 0, 6, 24, and 48 hrs at 37 °C, the amount of biofilm was measured. The results showed that 
CJC completely eliminates biofilm formation for all cultures. However, the isolated PACs 
reduced biofilm formation compared to the control, but did not eliminate biofilm formation. This 
may be related to the fact that PACs become unstable when they are removed from the juice 
environment or that PACs are not the only active components. These results revealed the need to 
further study non-PACs components.  
2.5.3 Atomic Force Microscopy (AFM) Studies of Bacterial-Uroepithelial Cell 
Interactions 
Our lab was the first to measure the adhesion forces between uropathogenic P-fimbrated 
E. coli and uroepithelial cells exposed to cranberry juice (0 2.5, 5, 10, and 27 wt%) directly by 
use of AFM [56]. In the presence of CJC, a decrease in adhesion forces between E. coli and the 
uroepithelial cells was observed and the adhesion forces were dose-dependent. Adhesion forces 
between E. coli HB101 (non-fimbriae bacteria served as a control) were relatively low and did 
not change significantly in CJC. 
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Further, our lab investigated the effects of cranberry metabolites in urine collected from a 
volunteer who had consumed CJC on several strains of uropathogenic E. coli [58], including P-
fimbriated strains (CFT073, B37, J96, and BF1023) and non-fimbriated but mannose-resistant 
hemagglutination demonstrating strains (B73 and B78). AFM results showed that within 2 hours 
after CJC consumption, bacteria of the clinical strains treated with the corresponding urine 
sample demonstrated lower adhesion forces than those treated with urine collected before CJC 
consumption. The adhesion forces continued decreasing with time after CJC consumption over 
the 8-hour measurement period, while the adhesion forces of bacteria after exposure to urine 
collected following water consumption did not change. But this research only used a single 
volunteer. Since different individuals might respond to CJC in various ways, more volunteers 
need to be involved to elucidate CJC’s effectiveness of control and treatment for UTIs. 
Previous studies in our lab have showed that for some cases, PACs alone do not have as 
great an anti-adhesion effect against E. coli as CJC [60]. The weaker performance of isolated 
PACs lead us to shift our research approach from studying the in vitro effects of cranberry juice 
or isolated PACs in our AFM adhesion assays to studying the metabolites in urine directly. In 
working with the urine samples, we believe it could remove uncertainties about whether the 
material is stable, and about how relevant these solutions are compared to what occurs in the 
body when a person consumes cranberry juice. The purpose of this study is to get a more detailed 
picture of when the anti-adhesive activity of urine peaks, to explore how long the anti-adhesion 
effect persists in the urine, and to understand the differences in how individual volunteers 
respond to CJC consumption.  
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Chapter III Effects of cranberry juice metabolites on uropathogenic 
Escherichia coli in vitro biofilm formation 
3.1 Abstract 
A double-blind, placebo-controlled pilot clinical trial of the effect of cranberry juice 
cocktail (CJC) consumption on biofilm formation was conducted in ten healthy women between 
the ages of 18 and 27. A single dose of 16 oz. of CJC or a placebo beverage was given to the 
volunteers, and urine samples were collected in the following 48 hours. A washout period of 
seven days was allowed. Bacteria (E. coli B37, CFT073, BF1023, HB101, and S. aureus 
ATCC43866) were cultured in the urine samples supplemented with media and the amount of 
biofilm formed was measured using a crystal violet absorbance assay in a 96-well plate. In the 
urine of volunteers who had consumed CJC, biofilm formation was inhibited within 24 hours 
after CJC consumption, and biofilm formation started to increase after 48 hours by 49-67%. S. 
aureus showed the least biofilm formation after incubation with post-CJC urine. The results 
indicated that drinking CJC can be an effective preventive measure for bacterial adhesion and 
biofilm formation in healthy women. The anti-biofilm activity peaks between 24 and 48 hours 
after drinking CJC. In addition, the viability assay results showed that the colony count after 
culturing in urine collected following consumption of CJC or placebo were not significantly 
different, implying that CJC works as an inhibitor by blocking bacterial adhesion instead of 
killing the bacteria or restraining its growth.  
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3.2 Introduction 
Escherichia coli (E. coli) strains have been considered as the most predominant cause of 
urinary tract infections (UTIs). As the first step of bacterial infection, biofilm formation, which 
hinders the eradication of bacteria [32] from the environment, is of significant interest to 
researchers [61]. Biofilms allow bacteria to persist a long time in the genitourinary tract and 
create more favorable conditions for colonization and infection. In addition, biofilm help the 
bacteria within it avoid immune system attacks and antibiotic treatments, which increase the 
difficulty of treating UTIs.  
Native American cranberry (Vaccinium macrocarpon) has been long known for its 
preventive benefits on UTIs. E. coli adhesins, mainly fimbrial in nature, promote bacterial 
adhesion to uroepithelial cells or urinary catheters, which is the first step in the development of 
biofilm formation and UTIs. The unique A-type linkages proanthocyanidins (PACs) in cranberry 
have been implicated as important inhibitors of primarily P-fimbriated E. coli attachment to 
uroepithelial cells. However, the activity of the post-ingested cranberry metabolites has not been 
greatly studied. The mechanisms of the anti-adherence effect and the nature of the anti-adherence 
compounds are still poorly understood. 
 Although cranberry products have been consumed by many healthy women as a 
preventive measure, further research is needed to elucidate how oral consumption of cranberry 
affects the activity of uropathogenic bacteria. Previous studies demonstrated that the active 
compounds are not destroyed in the body by the digestive system after intaking cranberry juice 
[58, 62]. However, no studies have identified the molecular structure of the effective components 
in urine. Additional experiments are required to investigate its persistence in urine samples over 
a broader time period, and to determine if the urinary anti-adhesion effect following cranberry is 
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detected within volunteers of different origins. By using human urine, this model could represent 
in vivo conditions. 
A limited number of studies have examined the role of cranberry on biofilm formation. 
DiMartino et al showed that cranberry juice consumption decreased biofilm development of 
uropathogenic E. coli on inert surfaces [63]. They used samples from two volunteers and tested 
the urine at a single time point. Another placebo-controlled clinical trial showed that UTIs were 
prevented in elderly women who had received cranberry juice therapy [14], but there have been 
few studies in younger age groups. We built upon prior research in several important ways, by 
examining more volunteers, testing the urine over a longer time (up to 48 hrs), and examining a 
wider range of uropathogenic strains. Therefore, the present study used a biofilm formation assay 
to determine the efficacy of cranberry juice cocktail (CJC) to reduce biofilm formation in the 
urine of ten healthy women, for 48 hours following CJC consumption. 
3.3 Subjects and Methods 
3.3.1 Healthy Volunteers 
Ten healthy female volunteers with a normal diet, ranging in age from 18 to 27 years, 
from the student population of Worcester Polytechnic Institute (Massachusetts) were recruited. 
The study was a double-blind, randomized, placebo-controlled and cross-over study. Exclusion 
criteria included confirmation that the ten volunteers had no history of urinary tract infections 
and the urine had a normal urine composition by a dipstick test. During this trial, the volunteers 
maintained their usual unrestricted diet but were asked to not consume any other berries or juices 
in order to exclude the intervention of metabolites possibly similar to cranberry metabolites. All 
volunteers were asked to sign their informed consent.  
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3.3.2 Study Protocol 
The double-blind study was carried out using commercially available cranberry juice 
cocktail (CJC; Ocean Spray Cranberries, Inc., USA) and placebo beverage. Ingredients include 
filtered water, cranberry juice concentrate (~27%), sucrose, aspartame, and ascorbic acid. The 
placebo beverage mimics the flavor and color of the cranberry beverage but has no cranberry 
ingredients or proanthocyanidins.  
Each volunteer received 16 oz (480 ml) of CJC or placebo. A wash-out period of at least 
one week was allowed. Urine samples were collected at 2, 8, 24, and 48 hours after CJC or 
placebo consumption. Baseline urine samples (indicated as 0 hour later) were taken before 
ingesting cranberry juice or placebo on the day of the study. All specimens and data were 
confidentially coded. In order to remove epithelial cells, bacteria, or other particles from the 
urine, the urine samples were centrifuged at 7000 RPM for 10 min, sterilized by filtration using 
polyethersulfone syringe filters (VWR International TM, West Chester, PA) with 0.8 μm and 0.2 
μm membranes sequentially, and stored at -20 °C for future use.  
3.3.3 Bacteria Cell Preparation  
Three clinical uropathogenic P-fimbriaed E. coli isolates (CFT073, B37, and BF1023) 
and a Staphylococcus aureus (S. aureus) strain (ATCC 43866) were used in this study. E. coli 
HB101, a non-pathogenic lab strain with no fimbriae that does not adhere to epithelial cells, 
served as a control. Pure cultures were maintained at -80 °C in colonizing factor antigen (CFA) 
media composed of 1% (w/v) casamino acids, 0.078% (w/v) yeast extract, 0.4 mM MgSO4, 0.04 
mM MnCl2, in ultrapure water, at a pH of 7.4. Cultures were streaked onto Tryptic Soy Agar 
(40g/L, Sigma-Aldrich, St. Louis, MO) plates that were then incubated at 37 °C for 24 h. The 
strains were cultured in Luria-Bertani broth (20g/L, Sigma-Aldrich, St. Louis, MO) at 37 °C with 
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gently shaking to enhance expression of P-fimbriae and then harvested at late exponential phase 
(corresponding to 0.9-1.0 optical density (OD) units at 600 nm).  
3.3.4 Crystal Violet Biofilm Assay 
The inhibitory effect of cranberry metabolites on the biofilm formation of E. coli CFT073, 
E. coli B37, E. coli BF1023, S. aureus ATCC 43866, E. coli HB101 on the bottom of 96-well 
PVC microtiter plates (BD Falcon, Durham, NC) was examined. Briefly, the harvested bacteria 
were mixed with urine samples at a ratio of 1: 1 (v/v %). The mixed suspension was transferred 
into a 96-well PVC microtiter plate and incubated at 37 ºC. After 0, 6, 24, 48 hours of incubation, 
media and unattached bacterial cells were decanted from the wells. 20 μL of crystal violet 
solution (Becton, Dickinson and Company, Sparks, MD) was added to stain bacteria cells for 15 
minutes. The microtitre plates were then washed three times with 200 μL of deionized water each 
time to remove the remaining planktonic or loosely bound bacteria cells. Bacteria cell-bound 
crystal violet was released by the addition of 150 μL of extracting agent (20% acetone in ethanol 
v/v) for 15 min at room temperature. The concentration of crystal violet, as the indicator of the 
amount of biofilm, was then quantified by measuring the absorbance of the solution at 600 nm 
with a microtiter plate reader. Each isolate was assayed in four replicate wells. 
3.3.5 Bacterial Cell Viability Assay 
Plate counts were used to verify loss of cell viability when suspended in urine collected 
after CJC or placebo consumption. Harvested bacterial cell suspensions were diluted in the same 
pre-warmed medium (Luria-Bertani broth) from 10 to 106 and mixed with the urine samples with 
a ratio of 1:1 (v/v %). Mixture with equal quantity of growth media was used as a control. The 
mixture was spread to Luria-Bertani argar (35g/L, Sigma-Aldrich, St. Louis, MO) plate and 
incubated at 37 °C for 24 h. The numbers of bacterial colony were counted. These measurements 
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were repeated using three different samples (prepared from separate cultures) of each bacterial 
dilution.  
3.3.6 Statistical Analysis 
3.3.6.1 Crystal Violet (CV) Biofilm Formation Assay 
For each volunteer, comparisons of the biofilm amount after post-CJC and post-placebo 
urine sample treatment were evaluated using one-way analysis of variance (abbreviated one-way 
ANOVA) method, following the variance examination with Tukey's test. For all the ten 
volunteers, the difference of biofilm formation in urine following consumption of cranberry juice 
cocktail or placebo was also examined by one-way ANOVA procedure, following with Tukey's 
Test. A value of P < 0.05 was considered statistically significant and the time point zero samples 
served as a baseline control. Results were reported as means ± standard deviation (SD) for all 
experiments. 
3.3.6.2 Bacterial Cell Viability Assay  
The statistical significance of differences was evaluated with Student’s t test for paired 
values. P values below 0.05 were considered significant. All experiments were performed in 
triplicate. 
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3.4 Results  
3.4.1 Effects of Cranberry Juice Metabolites on E. coli Biofilm Formation 
To determine cranberry juice metabolites’ anti-adhesive ability to clinical UTI isolates, 
biofilm formation assay (which represents a rapid screening method for bacterial adhesion 
abilities in 96-well microtitre plates) was conducted in this study.  
The inhibitory effects of cranberry juice metabolites on the five strains after 0, 6, 24, and 
48 hours incubation are presented in Figures 3.1 - 3.4, respectively. The adherence rates of the 
tested bacteria differed from strain to strain. For non-pathogenic E. coli HB101 (served as a 
control), the amount of biofilm formed after culturing in post-CJC urine stayed unchanged over 
48 hours and did not show a difference from the biofilm amount formed with post-placebo urine 
treatment for all incubation time points (0, 6, 24, and 48 hours). Before they had been put into 
the 37 °C incubator (Figure 3.1, 0 hour), E. coli B37, BF1023 did not show any difference in 
biofilm formation between the post-CJC and post-Placebo urine treatment. Only S. aureus and E. 
coli CFT073 exhibited a significant lower biofilm formation after drinking CJC for 24 hours and 
48 hours compared to placebo.  
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Figure 3.1 Amount of biofilm formed after incubation of 0 hour at 37 °C (A) E. coli HB101; 
(B) S. aureus; (C) E. coli CFT073; (D) E. coli B37; (E) E. coli BF1023.  indicates that 
biofilms formed in urine following ingestion of CJC or placebo were significantly different. 
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Figure 3.2 Amount of biofilm formed after incubation of 6 hour at 37 °C (A) E. coli HB101; 
(B) S. aureus; (C) E. coli CFT073; (D) E. coli B37; (E) E. coli BF1023.  indicates that 
biofilms formed in urine following ingestion of CJC or placebo were significantly different. 
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Figure 3.3 Amount of biofilm formed after incubation of 24 hour at 37 °C (A) E. coli 
HB101; (B) S. aureus; (C) E. coli CFT073; (D) E. coli B37; (E) E. coli BF1023.  indicates 
that biofilms formed in urine following ingestion of CJC or placebo were significantly 
different. 
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Figure 3.4 Amount of biofilm formed after incubation of 48 hour at 37 °C (A) E. coli 
HB101; (B) S. aureus; (C) E. coli CFT073; (D) E. coli B37; (E) E. coli BF1023.  indicates 
that biofilms formed in urine following ingestion of CJC or placebo were significantly 
different. 
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Table 3.1 Amount of biofilm formed after culturing in urine samples collected from volunteers drinking CJC or placebo for 6 hours. Biofilm 
amount at hour 0 serves as baseline. 
Strain Urine Sample Treatment 
Mean Absorbance at 600 nm ± SD  
0hr 2hr 8hr 24hr 48hr 
E. coli B37 Placebo 0.000 0.000 
0.021±0.193 0.030±0.170 0.157±0.410 0.213±0.427 
CJC -0.090±0.207 -0.121±0.136 -0.214±0.175* -0.090±0.254* 
E. coli CFT073 Placebo 0.000 0.000 
0.028±0.268 0.063±0.305 0.082±0.321 0.087±0.214 
CJC 0.000±0.216 -0.123±-0.182* -0.148±0.205* 0.041±0.227 
E. coli BF1023 Placebo 0.000 0.000 
0.011±0.058 -0.019±0.073 0.023±0.067 0.051±0.073 
CJC -0.020±0.067 -0.042±0.077 -0.045±0.058* -0.023±0.105* 
S.aureus 
(ATCC43866) 
Placebo 0.000 
0.000 
0.245±0.398 0.263±0.363 0.256±0.375 0.428±0.307 
CJC -0.057±0.222* -0.080±0.256* -0.274±0.212* -0.090±0.262* 
E. coli HB101 Placebo 0.000 0.000 
0.026±0.028 0.005±0.027 0.087±0.026 0.089±0.023 
CJC 0.142±0.033 -0.006±0.040 0.014±0.040 0.091±0.021 
* Statistically significant difference compared to the placebo group (p<0.05). 
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After incubation for 6 hours at 37 °C (Figure 3.2), for all the strains except E. coli HB101, 
the amount of biofilm decreased within 24 hours after CJC consumption and slightly increased 
between 24 and 48 hours after CJC consumption (Table 3.1). The trend for the quantity of 
biofilm formed after 24 hours of incubation (Figure 3.3) is similar to those incubated for 6 hours 
for all strains except E. coli CFT073, where the biofilm amount for the sample treated with 48 
hours post-CJC urine is a little higher than the one treated with 48 hours post-placebo urine. 
After 48 hours of incubation (Figure 3.4), the 24 hours post-CJC urine treatment reduced biofilm 
formation ability in all strains except E. coli HB101. However, only S. aureus and E. coli B37 
showed a significant decrease of biofilm formation in urine following consumption of CJC 
compared to that in urine collected after drinking placebo at the same time point. The 48 hours 
post-CJC urine treatment formed the same amount of biofilm as 48 hours post-placebo urine 
treatment, except for S. aureus. 
3.4.2 Individual Responses to CJC 
The inhibitors to prevent biofilm formation against E. coli may be transitory and can be 
affected by a number of factors, dietary (on salt and water balance) and environmental. For a 
given strain of bacteria, an individual was considered to be responsive to CJC if the biofilm 
amount after culturing in post-CJC urine was significant lower than that in post-placebo urine (P 
< 0.05).   
The number of volunteers who responded to CJC is summarized in Tables 3.2 - 3.5. The 
results demonstrated that the urine before drinking either CJC or placebo did not show any anti-
adhesive effects for all strains, at all incubation time points.   
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Table 3.2 Number of volunteers that showed a significantly lower biofilm formation in urine following 
consumption of CJC (total number of volunteers is 10) after incubation for 0 hour at 37 °C. 
Strain 
# of volunteers showing difference between CJC and placebo 
0hr 2hr 8hr 24hr 48hr 
E. coli B37 0 0 1 1 3 
E. coli CFT073 0 1 2 4 2 
E. coli BF1023 0 3 4 4 3 
S.aureus (ATCC43866) 0 2 1 6 6 
E. coli HB101 0 1 2 1 2 
 
After being incubated for 0 hours (Table 3.2), the number of volunteers who responded to 
CJC differed from strain to strain and there is no obvious trend among the treatment with urine 
collected before drinking CJC or placebo. 
 
Table 3.3 Number of volunteers that showed a significantly lower biofilm formation in urine following 
consumption of CJC (total number of volunteers is 10) after incubation for 6 hours at 37 °C. 
Strain 
# of volunteers showing difference between CJC and placebo 
0hr 2hr 8hr 24hr 48hr 
E. coli B37 0 4 4 8 6 
E. coli CFT073 0 3 5 5 5 
E. coli BF1023 0 1 2 3 4 
S.aureus (ATCC43866) 0 5 6 6 9 
E. coli HB101 0 1 3 4 2 
 
After incubation for 6 hours at 37 °C (Table 3.3), the results showed that within 24 hours 
after drinking CJC, the number of volunteers who showed a reduced biofilm formation increased, 
and this trend was similar in all the strains tested. The response at 48 hours after drinking CJC 
differed among the strains. E. coli BF1023 and S. aureus showed an increased number of 
responding volunteers at 48 hours compared to 24 hours, whereas for the other strains, the 
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number of volunteers who responded to CJC stayed unchanged or decreased, possibly because 
CJC has been washed out of the volunteer’s body. The degree of biofilm reduction also varied 
with bacterial strain; S. aureus had the most significant biofilm decrease, whereas E. coli 
BF1023 showed very little change after treatment with post-CJC urine. These variations may 
result from the different susceptibility of each strain to CJC treatment, and variant surface 
properties such as adhesin type and density. 
 
Table 3.4 Number of volunteers that showed a significantly lower biofilm formation in urine following 
consumption of CJC (total number of volunteers is 10) after incubation for 24 hours at 37 °C. 
Strain 
# of volunteers showing difference between CJC and placebo 
0hr 2hr 8hr 24hr 48hr 
E. coli B37 0 2 4 4 4 
E. coli CFT073 0 3 4 4 2 
E. coli BF1023 0 3 4 4 3 
S.aureus (ATCC43866) 0 4 4 5 6 
E. coli HB101 0 5 3 5 3 
 
The trend after 24 hours incubation (Table 3.4) is the same compared to that with 6 hours 
incubation but had decreased number of volunteers who responded to CJC except E. coli BF1023. 
 
Table 3.5 Number of volunteers that showed a significantly lower biofilm formation in urine following 
consumption of CJC (total number of volunteers is 10) after incubation for 48 hours at 37 °C. 
Strain 
# of volunteers showing difference between CJC and placebo 
0hr 2hr 8hr 24hr 48hr 
E. coli B37 0 3 5 4 5 
E. coli CFT073 0 3 3 3 3 
E. coli BF1023 0 1 2 3 3 
S.aureus (ATCC43866) 0 1 2 6 0 
E. coli HB101 0 1 2 3 1 
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After 48 hours incubation (Table 3.5), the number of responded volunteers further 
decreased compared to 24 hours incubation except E. coli B37. That is probably because the 
formed biofilm has already begun to decompose. 
3.4.3 Viability Assay and Correlation with Biofilm Assay 
To clarify whether cranberry juice metabolites behaved as anti-adhesive or anti-microbial 
agents, cell viability assay was measured.  
The effects of post-CJC consumption urine on bacterial colony number are summarized 
in Table 3.6. Cell viability also differed from strain to strain, and no significant drop in the 
number of colonies was observed for all strains after ingestion of cranberry (P < 0.5). For 
example, for E. coli CFT073, volunteer 7, the plate count after 24 hours of incubation in post-
CJC urine was 44.93 ± 32.63, in comparison to 47.47 ± 35.50 when suspended in post-placebo 
urine for 24 hours. Similarly, E. coli HB101, a strain lacking fimbriae structure that served as a 
control, showed no difference in colony counts (post-CJC urine was 7.20 ± 3.76, in comparison 
to 6.93 ± 3.10 in post-placebo urine, both for 24 hours). This indicates that the consumption of 
cranberry juice cocktail inhibits biofilm formation by possibly hindering bacterial adhesion 
activities rather than by killing the bacteria. 
E. coli CFT073 had the most colonies after culturing in post-consumption urine; S. 
aureus had a high colony count as well. These results were consistent with the results of the 
biofilm formation assay, in that E. coli CFT073 and S. aureus formed relatively more biofilm in 
post-placebo urine among all the clinical strains.  
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Table 3.6 Colony count of bacteria strains after 24 hours incubation in post-CJC urine or post-Placebo urine. 
Volunteer ID Urine Sample Treatment 
Strain 
E. coli B37 E. coli BF1023 E. coli CFT073 S. aureus E. coli HB101 
1 CJC 8.73 ± 4.62 13.93 ± 7.65 44.93 ± 32.63 23.87 ± 10.88 7.20 ± 3.76 
Placebo 11.60 ± 4.24 14.53 ± 8.50 47.47 ± 35.50 25.07 ± 6.50 6.93 ± 3.10 
2 CJC 18.27 ± 8.28 8.67 ± 5.68 32.13 ± 11.26 20.00 ± 11.18 7.07 ± 2.71 
Placebo 20.13 ± 8.85 9.25 ± 5.63 32.33 ± 8.82 23.33 ± 9.38 7.73 ± 2.69 
3 CJC 3.67 ± 2.02 12.73 ± 8.47 18.47 ± 3.34 21.13 ± 7.12 4.87 ± 1.85 
Placebo 4.40 ± 2.78 13.20 ± 6.76 18.40 ± 4.50 19.80 ± 6.94 6.13 ± 2.80 
4 CJC 23.00 ± 4.92 17.42 ± 8.87 21.25 ± 8.81 22.83 ± 9.52 5.08 ± 1.78 
Placebo 20.00 ± 3.02 17.92 ± 7.10 23.25 ± 10.97 22.00 ± 8.10 4.92 ± 1.68 
5 CJC 8.93 ± 8.41 11.47 ± 2.88 26.87 ± 17.18 30.60 ± 6.19 6.40 ± 5.29 
Placebo 17.73 ± 29.00 11.33 ± 2.89 29.93 ± 26.55 29.20 ± 5.83 6.33 ± 3.77 
6 CJC 18.33 ± 7.87 12.73 ± 5.01 36.00 ± 14.88 19.67 ± 7.07 5.40 ± 3.85 
Placebo 15.20 ± 6.73 13.27 ± 8.00 30.27 ± 10.82 23.93 ± 6.79 4.47 ± 2.85 
7 CJC 12.07 ± 8.42 7.80 ± 5.61 18.80 ± 6.01 21.47 ± 10.52 2.60 ± 1.59 
Placebo 12.07 ± 4.70 11.67 ± 4.86 18.33 ± 4.39 19.60 ± 6.77 3.47 ± 2.36 
8 CJC 7.47 ± 4.66 2.87 ± 1.19 76.40 ± 36.67 18.80 ± 6.98 5.73 ± 1.79 
Placebo 5.40 ± 4.91 4.60 ± 3.96 82.33 ± 36.73 19.47 ± 5.04 4.53 ± 2.26 
9 CJC 14.33 ± 8.87 12.93 ± 8.92 nt 13.92 ± 7.63 4.93 ± 2.09 
Placebo 15.67 ± 8.23 9.87 ± 10.49 nt 15.50 ± 8.45 4.87 ± 2.36 
10 
CJC 12.67 ± 3.92 10.80 ± 4.48 126.93 ± 61.57 25.40 ± 6.52 5.20 ± 2.73 
Placebo 15.20 ± 4.52 12.07 ± 3.24 104.80 ± 23.21 29.67 ± 7.64 4.33 ± 2.77 
All results are statistically non-significant (P < 0.05). nt=not tested
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3.5 Discussion 
3.5.1 Selection of Bacterial Strains 
To determine the efficacy of the consumption of cranberry juice versus placebo 
with regard to the presence of in vitro bacterial anti-adherence activity, several clinical 
strains of E. coli were cultured in the urine of healthy volunteers and tested for their 
ability to form biofilm in this study. Since our focus is on the type of adhesion that can be 
affected by PACs, we concentrated primarily on P-fimbriated E. coli strains.  
Uropathogenic E. coli strains typically demonstrate mannose-resistant adhesion in 
mannose-resistant hemagglutination (MRHA) experiments [64-66], but only cranberry 
can inhibit mannose-resistant adhesion [67, 68]. It is therefore important to investigate 
CJC’s anti-adhesive activity against uropathogenic E. coli strains that demonstrate 
MRHA. Several MRHA strains (P-fimbriated E. coli B37, CFT073 and BF1023) [58] 
were selected in this study.   
Table 3.7 Summary of properties and sources of five E. coli strains studied. All isolates also 
express type I fimbriae except S. aureus and HB101.  
Strain Fimbriae/Info Source 
B37 P-fimbriae from class II, 
ampicillin/sulfamethoxazole 
intermediate resistance 
Dr. James Johnson, VA Medical Ctr, 
Minneapolis, MN; isolated from female with 
cystitis [69] 
CFT073[WAM 
2267] 
Type P-fimbriae from class II  ATCC 700928; isolated from blood and urine 
of a woman with AP 
BF1023 P-fimbriae, class I and class III ATCC 700414; isolated  from a female 
patient with cystitis [70] 
S. aureus Surface protein [71] ATCC 43866  
HB101 Non-fimbriated, lab strain (non-
pathogenic control) 
ATCC 33694 
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The strains chosen cover a variety of surface properties and types of fimbriae 
(Table 3.7). For comparison, a strain that does not have P-fimbriae structure but is known 
to cause cystitis (S. aureus) and a control that does not cause infections (non-fimbriated E. 
coli HB101) were included. To represent different types of adhesins, a strain that 
expresses P-fimbriae from class II (E. coli CFT073) and a strain that expresses P-fimbriae 
from class I and class III (E. coli BF1023) were selected. While there is no direct 
connection between antibiotic susceptibility and sensitivity to cranberry compounds as an 
anti-adhesive therapy, it may be helpful in getting these therapies adopted if their health 
effects against pathogens which cannot be treated with common antibiotics can be 
demonstrated. Therefore, a clinical E. coli strain with known antibiotic resistance (E. coli 
B37) was also included in this study.  
3.5.2 Correlating Growth in Cranberry Metabolites and Development of 
Biofilms 
According to the results of the biofilm formation assay, after the volunteers drank 
CJC, their urine reduced biofilm formation in bacteria strains that have P-fimbriae (E. 
coli B37, CFT073, and BF1023), and surface protein (S. aureus [71]), whereas the strain 
that does not have adhesins, E. coli HB101, was not affected (Table 3.1). These results 
indicated that drinking CJC prevents biofilm formation. The extent to which biofilm 
formation was inhibited could differ based on the adhesin density and type. 
The duration of CJC’s effects on biofilm formation after oral consumption was 
also investigated. A previous study using human cell agglutination assay showed anti-
adhesion activity of urine lasted for 10 hours after CJC consumption [72]. In this study, 
the number of volunteers whose urine showed an inhibitory effect on biofilm formation 
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peaked between 8 and 24 hours after CJC consumption, and decreased in some strains 
after 48 hours. This phenomenon could be a result of cranberry components or 
metabolites’ washing out from the body. This may explain why the amount of biofilm 
increased 48 hours after consumption of CJC. 
3.5.3 Correlating Biofilm Formation and Pili Fimbriae Expression 
In the natural environment, bacteria are often found as communities in the form of 
biofilms. The attachment of individual cells to an available solid surface in the aqueous 
phase is the first step which could lead to the formation of mature biofilms. But the 
bacterium has to overcome the physical forces that repel bacteria from binding. In this 
case, pili structure on bacterium aid it to anchor to the surfaces firmly and mediate stable 
attachment further.  
E.coli CFT073 and B37 showed the most significant effects on biofilm formation, 
which is in a good agreement with the fact that majority of acute pyelonephritis cases 
(66%) are caused by P-fimbriated bacteria that contain Class II adhesins [73]. In addition, 
the bacterial cell viability assay demonstrated that for the amount of cranberry juice (16 
oz.) used in this study, the cranberry juice metabolites in collected urine following 
consumption do not have antibiotic effects, thereby reducing selective pressures for 
antibiotic resistant bacteria. Instead, they worked as an inhibitor to block bacterial 
adhesive activity. 
Although P-fimbriae with Class III adhesins are associated with 12% of cystitis 
cases in adult women [73], 37% of cystitis cases in children [74], and 13% of acute 
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pyelonephritis incidents [73], our results showed that cranberry juice does not work well 
with E. coli BF1023 which contains Class III adhesins besides Class I adhesins. 
S. aureus is one of the major causes of numerous hospital- and community-
acquired infections, including UTIs [71]. The widespread use of methicillin and other 
semisynthetic penicillins to treat it resulted in the emergence of methicillin resistant S. 
aureus [75]. Currently, greater than 60% of S. aureus isolates are resistant to methicillin 
[76]. S. aureus [75, 77] is therefore a growing public health problem in hospitals, nursing 
homes, and other institutions. This reinforced the critical need for new methods of control 
and treatment. Our results showed that there is essentially no biofilm formed in the S. 
aureus samples. This may suggest that oral consumption of CJC can be exploited as a 
treatment for Staphylococcal infections.
3.6 Conclusions 
  
In this study, two experimental assays were optimized successfully to demonstrate 
bacterial anti-adhesion activity of cranberry metabolites in human urine following 
cranberry juice cocktail consumption. The inhibitory effects for preventing biofilm 
formation in the urine of healthy young women could persist for at least 24 hours after 
CJC ingestion. The anti-adhesive ability differed based on the type of bacteria, suggesting 
biofilm formation is closely associated with the kind of P-fimbriae. Furthermore, the 
viability test results indicated that the cranberry metabolites in post-CJC urine behaved as 
an inhibitor to lower adhesive abilities rather than a bactericide to kill the bacteria. In 
other words, cranberry products do not impair bacterial growth and will not sterilize the 
urinary tract, although they prevent bacterial adhesive ability, thus reducing the 
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development of UTI. Since bacterial adhesion is the primary step in initiation of UTI, 
consumption of cranberry may be useful to help prevent infections. 
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Chapter IV Inhibitory activity of cranberry juice metabolites on adherence of P-fimbriated Escherichia 
coli to bladder epithelial cells  
4.1 Abstract 
Research suggests that cranberry may interfere with bacterial adhesion to 
uroepithelial cells, thus preventing UTIs. To date, few research studies have been 
conducted to examine the potential interaction of E. coli and uroepithelial cells in the 
presence of post-cranberry consumption urine. The current study is a randomized, 
placebo-controlled, double-blind, crossover study to investigate the molecular-scale 
effect of cranberry juice metabolites on two P-fimbriated E.coli strains: B37 and CFT073 
as assessed by atomic force microscopy (AFM). Three female subjects were asked to 
consume 8 oz cranberry juice cocktail or water. The washout period was 7 days. The 
urine samples were then collected at intervals of 2, 4, 6 hours post-ingestion of CJC or 
water. Additional urine before consumption of CJC was collected as a baseline control. 
The baseline average adhesion force between E. coli and uroepithelial cells was 13.09 ± 
11.60 nN for CFT073 and 10.30 ± 5.50 nN for B37. For post-CJC urine treatment, the 
adhesion forces decreased to 2.94 ± 1.82 nN at 2 hours after consumption then increased 
slightly to 5.51 ± 2.78 nN at 6 hours after ingestion for CFT073, while it decreased to 
4.77 ± 3.33 nN after consuming for 2 hours and seemed to be stable in the next 4 hours 
following consumption (5.52 ± 4.04 nN after drinking for 4 hours; 5.05 ± 4.42 nN after 
drinking for 6 hours) for B37. The adhesion forces in post-water consumption urine were 
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similar to that of the background for E. coli B37; meanwhile a downward trend for the 
adhesion forces in post-water consumption compared to the background was observed for 
E. coli CFT073. However, those adhesion forces in post-water consumption urine were 
still higher than those measured after CJC consumption at the same time intervals. The 
mean differences between the cranberry and placebo groups were statistically different 
according to two way ANOVA method followed by Holm-Sidak test. Our results suggest 
a significant inhibitory interaction between the daily consumption of 8 oz cranberry juice 
and bacteria adhesive activity.  
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4.2 Introduction  
Urinary tract infection has been considered one of the most significant infections 
affecting humans today. It is usually caused by the presence of bacteria in the urinary 
tract system [19], especially Escherichia coli (E. coli) [3, 8]. Cranberry (Vaccinium 
macrocarpon) has been utilized to protect against UTIs for generatons [6, 15, 16, 29]. 
The unique A-type proanthocyanidins (PACs) present uniquely in cranberry have been 
identified as the active agent to prevent P-fimbriated E. coli to attach to uroepithelial cells 
[17, 18]. However, the activity of cranberry metabolites in urine following ingestion of 
cranberry juice cocktail is still unclear and the active compounds remain unidentified. 
Due to the limited molecular knowledge of its inhibitory effect, cranberry products have 
not been integrated into established medical care regimes successfully. 
As the first step in the development of infection, bacterial adhesion is of great 
research interest. In this study, a biofilm assay (Chapter III) was used to detect bacterial 
anti-adhesion activity of metabolites in urine following consumption of cranberry juice 
cocktail. Although interesting results were obtained, the biofilm assay does not describe 
adhesion at the molecular level. The lack of quantitative data on the adhesive interactions 
between bacterial cells and uroepithelial cells in the presence of urine which contains 
post-consumption cranberry metabolites limits its current use for UTI treatment. 
Understanding of how cranberry affects the interaction between bacteria and epithelial 
cells lining the urinary tract is important and helpful to provide the mechanisms by which 
cranberry metabolites inhibit the adhesion of E. coli to uroepithelial cells.  
AFM is a sensitive tool and can be used to directly measure the nano-scale forces 
of attraction or repulsion between virtually any two surfaces. A technique to 
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quantitatively measure the adhesive interactions between a bacterium and a surface or 
between two biological surfaces is developed by our lab [78] using AFM. By directly 
quantifying such interactions between P-fimbriated E. coli and human uroepithelial cells 
exposed to post-CJC consumption urine, the molecular mechanisms by which cranberry 
juice cocktail (CJC) affects bacterial adhesion could be revealed and mechanistic 
understanding will allow for the development of the best therapies and measures to 
prevent infections.  
In order to elucidate time-dependence of these mechanisms and variability for 
different volunteers, the adhesive interactions between P-fimbriated E. coli and 
uroepithelial cells will be directly and quantitatively characterized in this study. Two 
clinical Class II P-fimbriated E. coli strains (B37 and CFT073) that showed the most 
significant decreases in biofilm formation in Chapter III were chosen. The effect of the 
time to which a peak in anti-adhesive activity is reached will be quantified.  
4.3 Materials and Methods 
4.3.1 Subjects and Collection of Urine Samples  
Female subjects were recruited by Dr. Amy Howell at Rutgers University (New 
Jersey). Although the present application is not a clinical study and does not involve 
human subjects, information is provided about the participants for information purposes. 
Volunteers were not allowed to eat or drink any cranberry products for at least three days 
prior to and on the day of urine collection. Volunteers were provided and asked to 
consume 8 oz. (240 mL) of commercial cranberry juice cocktail (CJC), or water. A 
washout period for at least seven days was used. On the day of the study, the urine before 
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consumption of CJC was collected as a baseline control. Additional urine samples were 
then collected at intervals of 2, 4, 6 hours post-ingestion of CJC or water. Samples were 
frozen immediately and sent to Dr. Terri Camesano’s laboratory at Worcester Polytechnic 
Institute (WPI, MA) with a code number only for de-identified purposes. At WPI, 
samples were sterilized by filtering by polyethersulfone syringe filters (VWR 
International TM, West Chester, PA) with 0.8 μm and 0.2 μm membranes sequentially, 
and stored at -20 °C for future use.  
4.3.2 Preparation of Bacteria Cell  
Bacterial samples tested in this study were two clinical P-fimbriaed E. coli 
isolates (B37 and CFT073), The strains were cultured in Luria-Bertani broth (35g/L, 
Sigma-Aldrich, St. Louis, MO) at 37 °C with gentle shaking and harvested at late 
exponential phase (optical density = 0.9-1.0 at 600 nm), which allowed them to express P 
fimbriae. Harvested bacteria were washed to remove components of the growth media by 
centrifugation at 7000 RPM for 10 min.  
4.3.3 Preparation of Biological Probes  
A single E. coli bacterium was immobilized onto an AFM tip using a technique 
developed in our lab [5, 78]. Briefly, the probe was coated with ply-L-lysine (PLL) by 
immersing in 0.1% PLL for 30 min and air dried for 10 min. The probe was then 
immersed in a concentrated bacteria suspension for 10 min to allow bacteria to bind on 
the probe. After air drying for 10 min, the biologically functionalized tip was ready for 
future use to measure the adhesion forces between E. coli and a lawn of uroepithelial 
cells. 
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4.3.4 Uroepithelial Cell Culture 
Human bladder uroepithelial cells were used in this study. SV-HUC-1 cell line 
was purchased from the American Type Culture Collection (ATCC) and maintained in 
liquid nitrogen vapor phase. The cells were grown in F-12K Medium (Kaighn’s 
modification of Ham’s F12 medium with L-glutamine, ATCC) supplemented with 10% 
fetal bovine serum (ATCC). Culture flasks were placed in a humidified atmosphere of 5% 
CO2
79
 in air at 37°C for seven days, and growth medium was replaced every two days. 
Trypsin-EDTA solution (0.25% Trypsin / 0.53 mM EDTA, ATCC) was added to harvest 
the uroepithelial cells as the low concentration of trypsin allowed us to detach the cells 
from the culture flasks without compromising their viability or surface properties [ ]. 
The cells were kept in trypsin-EDTA for no more than 10 min in an incubator (5% CO2
4.3.5 Preparation of Uroepithelial Cell Glass Slide for AFM Measurements 
, 
37 ℃), washed, centrifuged at 1200 RPM for 6 min, and resuspended in pre-warmed 
growth medium gently.   
For bacterial adherence assay, early passage cells (passage < 50) were seeded to a 
sterilized glass slide (Corning Incorporated, Corning, NY) and grown to 90% confluence. 
Briefly, the resuspended cells were cultured in the 35 mm Tissue Culture Treated Dish 
(Sarstedt, Inc. Newton, NC) containing a glass slide with growth media. The culture dish 
was placed in an incubator (5% CO2, 37 ℃) to allow the cells to attach the surface of the 
glass slide. After two days incubation, the glass slide with a cell-layer lawn was obtained. 
4.3.6 AFM Adherence Force Assays  
Adhesion forces were measured with AFM (Asylum Research, Santa Barbara, 
CA), with all measurements performed in the presence of urine following consumption of 
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CJC or water (Figure 4.1). Silicon nitride AFM tips on a triangular cantilever (DNPS, 
Veeco Metrology) were used to acquire images in fluid in tapping mode. Before force 
measurements were made, the spring constant of the cantilever was measured using the 
thermal calibration method.  The average spring constant was 513.3 ± 94.4 pN/nm. A 
human uroepithelial cell culture was maintained, and the adhesion force measurements 
between epithelial cells and bacteria were carried out in urine samples, and at least three 
individual cells were probed, where at least ten force cycles were recorded per bacterium 
per condition.  
 
Figure 4.1 Schematic demonstrating AFM experiments to measure cell-cell interactions. An E. 
coli cell is binded to an AFM cantilever (silicon or silicon nitride have been used successfully in 
our lab). Interaction forces are measured between the biological functionalized probe and a lawn 
of epithelial cells, grown and attached on a glass slide.  
 
4.3.7 Statistical Analysis 
A two way ANOVA test was performed to compare the two groups that were 
treated with urine samples collected after CJC or water consumption. Background 
(bacteria treated with urine samples that were collected before drinking CJC) adhesion 
forces were also compared with adhesion forces measured on the bacteria treated with 
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urine samples that were collected after consumption of CJC or water. The statistical test 
used was Holm-Sidak method. 
4.4 Results 
4.4.1 Adhesion Forces between E. coli Bacteria and Uroepithelial Cells  
For two bacterial strains, the P-fimbriated E. coli B37 and E. coli CFT073, 
adhesion forces to the bladder epithelial cells using bacterial probe were measured. The 
average adhesion forces between both of the P-fimbriated bacteria (E. coli B37 and 
CFT073) and uroepithelial cells were decreased in post-CJC consumption urine 
compared to the background (pre-CJC consumption urine) and the post-water 
consumption urine at the same time intervals as well.  
In the absence of any treatment, the average adhesion force between E. coli 
CFT073 and uroepithelial cells was 13.09 ± 11.60 nN (Figure 4.3), while it was 10.30 ± 
5.50 nN between E. coli B37 and uroepithelial cells (Figure 4.2). After CJC treatment, 
the adhesion forces between E. coli CFT 073 and uroepithelial cells decreased to 2.94 ± 
1.82 nN at 2 hours after consumption, and then it increased slightly to 5.51 ± 2.78 nN at 6 
hours after ingestion. The adhesion forces between E. coli B37 and uroepithelial cells 
decreased to 4.77 ± 3.33 nN after consuming for 2 hours and seemed to be stable in the 
next 4 hours following consumption (5.52 ± 4.04 nN after drinking for 4 hours; 5.05 ± 
4.42 nN after drinking for 6 hours). The adhesion forces in post-water consumption urine 
were similar to that of the background for E. coli B37 (Figure 4.2); meanwhile a 
downward trend for the adhesion forces was observed for E. coli CFT073 (Figure 4.3), 
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especially at 4 hours. However, those adhesion forces in post-water consumption urine 
were still higher than those measured after CJC consumption at the same time intervals.  
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Figure 4.2 Average adhesion forces between E. coli B37 and uroepithelial cells as a function 
of urine colleting time (hour) after consumption of CJC or water. Data are mean ± SD 
values. *Adhesion forces detected in urine following ingestion of CJC or placebo were 
significantly different. **The difference compared to background (pre-consumption urine) 
was significant.  
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Figure 4.3 Average adhesion forces between E. coli CFT073 and uroepithelial cells as a function 
of urine colleting time (hour) after consumption of CJC or water. Data are mean ± SD values. 
*Adhesion forces detected in urine following ingestion of CJC or placebo were significantly 
different. **The difference compared to background (pre-consumption urine) was significant. 
When we compared each condition at same time point with one another, adhesion 
forces in all post-CJC urine treatment were significantly lower than that of post-water 
urine treatment for both the clinical strains. Only the adhesion forces between E. coli 
CFT073 and uroepithelial cells in post-water consumption urine were significantly 
different compared with background adhesion force levels.  
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4.4.2 Volunteer Variability 
The inhibitory effects of cranberry juice metabolites on the two E. coli strains 
(B37 and CFT073) for individual volunteer are summarized in Figure 4.4. The anti-
adhesive of ability on the tested bacteria differed from volunteer to volunteer. Adhesion 
reduction was found to be dependent on the time treatment of cranberry juice as well.  
Table 4.1 Number of volunteers (total number of volunteers involved is 3) that showed a 
significantly lower adhesion forces between E. coli and uroepithelial cells in the presence of post-
CJC consumption urine. 
Strain 
# of volunteers showing difference between CJC and placebo 
2hr 4hr 6hr 
E. coli B37 3 2 2 
E. coli CFT073 3 2 1 
 
All volunteers’ urine (100%) had a significant anti-adhesive effect on E. coli 
strains at 2 hours following consumption, while at 4 hours, only 67% of volunteers 
responded to CJC. At 6 hours, E. coli B37 still works as it was on 4 hours, but E. coli 
CFT073 fell down to 33%. 
4.5 Discussion 
4.5.1 Bacteria Coated AFM Tips Preparation 
To verify that the AFM tip was successfully coated with bacteria, adhesion forces 
between a bare silicon nitride probe and a clean glass slide were measured. The 
interactions detected between bare silicon nitride and glass was minimal compared to the 
force profile between the E. coli biological probe and the glass, which were generally in 
the nano-Newton (nN) range, indicating that bacteria were binded to AFM tip 
successfully using the method developed in our lab. 
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4.5.2 Role of Cranberries in P-fimbriated E. coli Adhesion to Epithelial Cells 
Daily consumption of cranberry juice cocktail has been recommended to prevent 
urinary tract infections mainly caused by E. coli, and P-fimbriae is considered to play a 
significant role among virulence factors [80]. Therefore, this study focused on cranberry 
metabolites’ ability to inhibit the binding of P-fimbriae on pathogenic E. coli to the gal-
gal receptor on the epithelial cell, which is a very strong bond [18, 57].  
It has been known that most kidney infections arise from bladder infections 
through an ascending route [81]. Therefore, the initial adhesion of the pathogen may 
occur to bladder epithelial cells, and then P-fimbriated uropathogens can migrate to the 
kidney, causing acute pyelonephritis [82]. That is the reason why bladder uroepithelial 
cell line rather than kidney uroepithelial cell line is chosen in this study. 
Our AFM results showed that urine from subjects who drank CJC experienced a 
significant reduction in bacterial adherence to uroepithelial cells compared to when the 
same volunteer drank water. For E. coli B37 particularly, the antibiotic resistant strain, 
water consumption did not affect the adhesion forces compared to a significant decrease 
after CJC consumption, and adhesion was also insensitive to time after consumption 
(Figure 4.2). This is in a good agreement with one earlier study by Tao et al. from our 
laboratory [58]. These experiments demonstrated that the protocol and methodology 
developed in our lab can be used to detect molecular level differences in adhesion forces 
that are caused by consumption of CJC. The reduced anti-adhesive activity may be the 
result of some components in cranberry juice interacting with P-fimbriae directly, causing 
P-fimbriae to become compressed and less adhesive immediately. In addition, a 
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significant time-dependent decrease in bacterial in vitro adherence was encountered after 
cranberry consumption.  
Although previous study showed that the presence of cranberry juice could 
change the surface characterization of bacteria significantly [57] and PACs in cranberry 
could block bacterial swarming motility completely [83], whether PACs are the only 
compounds responsible for preventing and treating UTIs remain unknown. It has been 
demonstrated the effects of PAC on bacterial adhesion to and invasion of kidney 
epithelial cells [84]. Furthermore, our study showed that cranberry metabolites could 
block bacterial adhesive ability and invasion of bladder epithelial cells. However, the role 
of PAC metabolites to this phenomena are still not clear, further studies are needed to be 
conducted to investigate whether the metabolites in urine are from uniquely PACs or 
non-PAC compounds. As invasion of uroepithelial cells is a key step in the development 
of a UTI, our results exhibited that active agents could survive from the digestive system 
and held the promising future to treat UTIs.  
4.5.3 Time Dependence of CJC’s Inhibitory Effects  
In recent studies [85, 86], a significant bacterial anti-adhesion activity was 
observed in urine samples collected from volunteers that consumed cranberry powder 
compared to placebo. And it was dose-dependent [85, 86] and still working until 24 hours 
after consuming 72 mg of PAC [85]. Howell et al. [18] demonstrated that 0-6 hour 
following CJC consumption responded to the most important elimination period of PACs 
(which is recognized as the active agents in cranberry) in urines, that is why 0-6 hour (at 
intervals of every two hours) after CJC ingestion  were chosen to collect the urine in this 
study. 
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This randomized, double-blind versus placebo study revealed a time dependent 
effect in in vitro model of E. coli adherence to bladder epithelial cells. We demonstrated 
a peak of urinary anti-adhesion activity 2 hours after consumption of 8 oz. commercial 
cranberry juice cocktail. One previous study in our lab also showed that anti-adhesive 
ability of post-consumption urine on E. coli strains peaked at 6 h after 16 oz. CJC 
ingestion and were still working after drinking 8 hours [58]. When it comes to 8 oz. in 
this study, most significant difference was observed at 2 hours following consumption, 
which is most probable because this effect has a dose-dependent relationship. In other 
words, the more CJC the volunteer received, the longer this anti-adhesive effect last.  
For the experiments designed to test the effect of time after consumption, urine 
samples were collected at intervals of 0, 2, 4, and 6 hours after consumption of cranberry 
juice. The AFM results showed that cranberry juice has an immediate effect (after 
consuming CJC for 2 hours) on the P-fimbriated E. coli bacteria. When cultured with 
urine samples collected at different time intervals following CJC consumption, both of 
the clinical E. coli strains demonstrated decreased adhesion forces after initial CJC 
consumption but increased slightly with time (Figures 4.2-4.3). Although this is an in 
vitro model, our work suggests that continuous exposure to cranberry juice will be 
needed in order for E. coli to maintain an anti-adhesive behavior in the body. 
4.6 Conclusions 
UTIs are infections caused by invading of bacteria and the adhesive ability of 
these microorganisms seems to be an important pathogenic factor. Cranberry metabolites 
present in urine collected following consumption of CJC were examined for their 
potential to reduce the initial adhesion of uropathogenic bacteria to bladder epithelial 
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cells. For both of E. coli B37 and CFT073, two strains expressing P-fimbriae Class II, 
most significant inhibition of bacterial adhesion was observed for the condition where 
cranberry juice cocktail was taken after 2 hours and it was still working over 6 hours 
following consumption. The results of this study are promising for cranberry juice 
cocktail as a proposed dietary treatment which is independent of antibacterial 
mechanisms that may give rise to resistant strains.  
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Chapter V Research Summary 
Although cranberry has been known for its health benefits to prevent urinary tract 
infections for quite a long time, the mechanisms are still not clear. The initial adhesion of 
pathogens to host tissue cells may be the first in a series of steps leading to the infection. 
In order to elucidate the anti-adhesive activity at molecular scale, this study investigated 
the inhibitory effects of cranberry metabolites in post-CJC consumption urine on 
pathogenic E. coli.  
In Chapter III, we evaluated the persistence of cranberry metabolites in urine and 
its effects on biofilm formation and bacterial cell viability. The results demonstrated that 
biofilm formation was inhibited significantly for S. aureus and E. coli containing Class II 
P fimbrie, suggesting bacterial adhesive ability is closely associated with the expression 
of pili fimbriae. In addition, the viability test results confirmed that the cranberry 
metabolites in post-CJC urine behaved as an inhibitor to block the expression of pili 
fimbriae rather than a bactericide to kill the bacteria or restrain its growth. 
In Chapter IV, we measured the adhesion forces directly between E. coli and 
uroepithelial cells in the presence of urine following consumption of CJC or water though 
atomic force microscopy. We determined that exposure to urine collected after drinking 
CJC reduced the adhesion forces significantly for both of our E. coli strains (P-fimbriated 
B37 and CFT073). This indicated that cranberry constituents could survive from the 
digestive system in our body and cranberry metabolites exhibited a significant bacterial 
anti-adhesive ability and this inhibition was clearly time-dependent.  
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Through these analyses, information on the dose of cranberry juice needed to 
provide an anti-adhesion benefit, the time of exposure acquired between E. coli and the 
cranberry metabolite in urine, and the variability in response due to different clinical 
strains of E. coli and the behavior of different volunteers was obtained. This work can 
help establish conditions that should be used in subsequent clinical trials. 
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Chapter VI Future Work 
American cranberry has long been recognized for its preventive benefits to 
maintain urinary tract health; however, it is too acidic and astringent at full strength and 
may not be acceptable to many patients as a prophylactic therapy over a long period. 
Cranberry juice cocktail and cranberry tablets have been introduced in this context. 
However, few dose-response studies have been done to determine the optimal volume of 
juice or number of tablets needed to prevent infection. We will further detect the 
adhesion forces between uropathogenic E. coli and uroepithelial cells in presence of post-
16 oz CJC urine through AFM and compare the results with adhesion forces obtained in 
the treatment of post-8 oz CJC urine. We might also extent the E. coli strains to cover 
more kind of adhesions. 
Our results showed that urine collected after administration of cranberry juice can 
prevent biofilm formation by E. coli but the nature of the metabolites is unknown. To our 
knowledge, the identity of such metabolites has not been explored, nor their role in 
bacterial susceptibility. It therefore may be of interest to examine possible contributions 
by any of the compounds present in cranberry fruit as well as their metabolites found in 
the human body.  
Although A-PACs are identified and widely recognized as the potential effective 
components in cranberry that reduce bacterial adhesion, it remains a question whether 
PACs are the only or major anti-adhesion components in cranberry, since some studies 
showed that cranberry juice had a higher anti-adhesion activity than A-PACs alone [60].
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In addition, new research has suggested that bacteria that do not express P fimbriae, 
including other strains of E. coli as well as different species of bacteria, can also express 
anti-adhesive activity in the presence of cranberry juice [40, 60, 87]. These results 
suggest that compounds in cranberry, in addition to PACs, also have anti-adhesion 
activity. Further, PACs have not been detected in urine. Therefore, further experiments 
needed to determine the relative anti-biofilm efficacy of the CJC, cranberry PACs, and 
non-PAC components of cranberry juice.  
The kinetic information of binding between cranberry compounds and pathogenic 
bacteria and/or the uroepithelial cell is still lacking, even though direct measurements of 
adhesion forces between uropothogenic E. coli and uroepithelial cells are made. To 
understand the dynamics and efficacy of cranberry compounds as an anti-adhesive 
therapy, the kinetic information is particularly of importance. Therefore, we will quantify 
the binding affinity and monitoring the kinetics of bacterial binding with epithelial cells, 
using Quartz crystal microbalance with dissipation monitoring (QCM-D).  
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Appendices 
Appendix A: Support File for Chapter III  
 
 
Part I: An example of relative amount of biofilm formed after bacteria strain 
was incubated in urine following consumption of CJC or placebo for an individual 
(volunteer 1). Biofilm amount at hour 0 serves as baseline. 
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Figure S.1 Amount of biofilm formed for S. aureus in urine of volunteer 1 collected following 
consumption of CJC or placebo after incubation for (A) 0 hour; (B) 6 hours; (C) 24 hours; (D) 
48 hours 
(A) (B) 
(c) (D) 
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(A) (B) 
(c) (D) 
Figure S.2 Amount of biofilm formed for E. coli CFT073 in urine of volunteer 1 collected 
following consumption of CJC or placebo after incubation for (A) 0 hour; (B) 6 hours; (C) 24 
hours; (D) 48 hours. 
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(A) (B) 
(c) 
(D) 
Figure S.3 Amount of biofilm formed for E. coli B37 in urine of volunteer 1 collected 
following consumption of CJC or placebo after incubation for (A) 0 hour; (B) 6 hours; (C) 24  
hours; (D) 48 hours. 
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(A) (B) 
(c) (D) 
Figure S.4 Amount of biofilm formed for E. coli HB101 in urine of volunteer 1 collected 
following consumption of CJC or placebo after incubation for (A) 0 hour; (B) 6 hours; (C) 24  
hours; (D) 48 hours. 
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(A) (B) 
(c) (D) 
Figure S.5 Amount of biofilm formed for E. coli BF1023 in urine of volunteer 1 collected 
following consumption of CJC or placebo after incubation for (A) 0 hour; (B) 6 hours; (C) 24  
hours; (D) 48 hours. 
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Part II: Individual responded to CJC in biofilm formation assay recorded in 
detail. 1 (in black) indicates biofilm formation in post-CJC urine was significantly lower 
than that in post-Placebo urine. 1 (in grey) indicates biofilm formation in post-CJC urine 
was significantly higher than that in post-Placebo urine. 0 indicates biofilm formation 
after culturing in urine collected following consumption of CJC or placebo are non-
significant (P <0.5). 
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Table S.1 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for S. aureus incubated for 0 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 1 0 0 0 1 0 1 0 
8 0 0 0 0 0 1 0 0 1 1 0 
24 0 1 1 1 0 0 1 1 0 1 1 
48 0 1 1 1 0 0 1 1 0 1 1 
 
 
 
Table S.2 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for S. aureus incubated for 6 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 1 0 0 0 1 1 1 0 0 1 
8 1 1 1 0 0 1 1 1 1 0 1 
24 1 1 0 0 0 1 1 1 1 0 1 
48 1 1 1 1 0 1 1 1 1 1 1 
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Table S.3 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for S. aureus incubated for 24 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 1 0 0 0 1 0 1 0 0 1 
8 1 0 0 1 0 1 1 1 0 0 1 
24 1 0 1 0 0 1 0 1 0 1 1 
48 1 1 0 0 0 1 1 1 0 1 1 
 
 
 
Table S.4 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for S. aureus incubated for 48 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 1 0 1 0 0 0 0 0 1 0 
8 0 0 1 1 0 0 1 0 1 1 0 
24 1 0 0 1 1 1 0 1 1 1 1 
48 0 0 1 1 1 0 0 0 0 1 0 
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Table S.5 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli CFT073 incubated for 0 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 1 0 0 0 0 0 0 0 
8 0 0 0 0 1 0 0 1 1 1 0 
24 1 0 0 1 1 0 0 0 0 1 1 
48 0 0 0 1 0 0 0 0 0 1 1 
 
 
 
Table S.6 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli CFT073 incubated for 6 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 1 0 1 0 0 0 0 1 1 0 
8 1 1 0 1 1 1 0 1 0 1 1 
24 1 1 0 0 1 0 1 1 1 0 1 
48 1 1 0 1 1 1 1 0 1 0 0 
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Table S.7 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli CFT073 incubated for 24 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 1 0 1 0 0 0 1 1 1 0 
8 1 1 0 1 1 0 0 1 1 1 0 
24 1 1 0 1 1 0 0 1 1 0 0 
48 0 1 0 1 1 0 0 1 1 0 0 
 
 
 
Table S.8 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli CFT073 incubated for 48 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 1 1 0 0 0 1 0 1 0 0 
8 1 1 0 0 0 0 0 1 1 0 0 
24 1 1 0 1 0 0 0 1 1 1 0 
48 1 1 0 0 1 0 0 1 1 0 0 
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Table S.9 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli B37 incubated for 0 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 1 1 1 0 
8 0 0 1 1 0 0 0 1 0 1 0 
24 0 0 0 1 0 0 0 1 1 0 0 
48 0 1 0 0 0 1 0 1 1 1 0 
 
 
 
Table S.10 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli B37 incubated 6 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 1 1 1 0 1 0 0 0 0 0 
8 1 0 1 1 1 0 0 0 0 0 0 
24 1 1 1 1 1 1 0 0 1 1 1 
48 1 1 1 1 0 1 0 0 0 1 1 
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Table S.11 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli B37 incubated for 24 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 0 0 0 0 0 0 0 1 0 0 
8 1 0 0 0 0 1 0 1 0 1 1 
24 1 0 0 0 0 1 0 1 0 1 1 
48 0 1 1 1 0 0 0 0 0 1 1 
 
 
 
Table S.12 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli B37 incubated for 48 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 1 1 0 0 0 0 0 0 1 0 
8 1 1 1 0 0 1 0 0 0 1 1 
24 1 1 1 0 0 0 0 0 0 1 1 
48 0 1 1 0 1 0 0 0 1 1 0 
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Table S.13 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli HB101 incubated for 0 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 1 0 0 0 1 0 0 0 0 0 
8 1 0 0 1 1 0 1 0 0 1 0 
24 1 0 0 0 0 1 1 0 0 0 0 
48 0 1 0 0 0 0 1 0 1 0 0 
 
 
 
Table S.14 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli HB101 incubated for 6 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 1 1 1 0 0 0 0 1 0 
8 1 0 1 1 1 0 0 1 0 0 0 
24 1 0 1 1 0 0 0 1 1 0 0 
48 1 0 0 1 0 0 0 0 1 0 0 
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Table S.15 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli HB101 incubated for 24 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 0 1 1 0 0 1 1 1 1 0 
8 1 1 1 0 0 0 0 0 0 1 0 
24 1 1 1 0 0 0 0 1 1 0 0 
48 1 1 0 0 0 0 1 0 1 0 0 
 
 
 
Table S.16 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli HB101 incubated for 48 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 1 1 0 0 0 0 0 0 1 0 
8 0 0 1 0 0 0 0 1 0 0 0 
24 1 0 1 0 0 0 1 1 0 0 0 
48 0 1 0 0 0 0 1 0 0 0 0 
  
Appendix 
 
- 81 - 
 
 
 
Table S.17 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli BF1023 incubated for 0 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 0 0 1 1 1 0 1 0 0 0 
8 1 1 0 1 1 0 0 1 0 1 0 
24 0 1 0 0 1 0 1 1 1 0 0 
48 0 1 0 0 1 0 1 1 0 0 0 
 
 
 
Table S.18 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli BF1023 incubated for 6 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 0 0 0 0 0 0 1 0 0 
8 1 0 0 0 0 0 0 0 1 0 0 
24 1 0 0 0 0 0 0 1 1 0 1 
48 1 0 1 0 0 0 0 1 1 0 1 
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Table S.19 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli BF1023 incubated for 24 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 1 1 1 1 0 0 0 0 0 0 0 
8 1 1 0 1 0 0 1 0 1 0 0 
24 1 1 1 1 1 0 0 0 1 0 1 
48 0 1 1 1 0 1 0 0 1 0 1 
 
 
 
Table S.20 Individual volunteer responded to CJC in biofilm formation assay recorded in detail for E.coli BF1023 incubated for 48 hours. 
Urine collecting time Volunteer ID 
(hours) 1 2 3 4 5 6 7 8 9 10 ALL 
0 0 0 0 0 0 0 0 0 0 0 0 
2 0 0 1 1 0 0 0 0 0 0 0 
8 0 1 1 1 0 0 0 0 0 0 0 
24 0 1 1 1 0 0 1 0 1 0 0 
48 0 1 1 1 0 0 0 0 1 0 0 
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Part III: An example of measured absorbance at 600 nm took by a microtiter 
plate reader.  
 
 
Figure S.6 An example of measured absorbance at 600 nm took by a microtiter plate reader. 1-5 
indicate biofilm formation of E. coli CFT073 after culturing in urine collected following 
consumption of CJC for 0, 2, 8, 24 and 48 hours, respectively. 7-11 represent biofilm formation 
of E. coli CFT073 after incubating in culturing collected following ingestion of placebo for 0, 2, 8, 
24 and 48 hours, respectively. 6 and 12 are blank.  
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Part IV: An example of colony count in bacterial cell viability assay. 
 
 
Figure S.7 A photograph of a representative example of colony count of E. coli CFT073 after 
incubated in urine collected following consumption of CJC (left) or placebo (right) for 24 hours. 
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Appendix B: Support File for Chapter IV 
 
Part I: Average adhesion forces between pathogenic E. coli and uroepithelial 
cells detected by atomic force microscope for each volunteer.   
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Figure S.8 Adhesion forces between E. coli B37 and uroepithelial cells as a function of urine 
colleting time (hour) after consumption of CJC or water for volunteer 1. *Adhesion forces 
detected in urine following ingestion of CJC or placebo were significantly different. **The 
difference compared to background (pre-consumption urine) was significant.  
 
 
 
 
 
 
 
 
 
Appendix 
 
- 87 - 
 
 
Background 2 hours 4 hours 6 hours
0
5
10
15
20
25
30
35
40
Ad
he
sio
n 
Fo
rc
e 
(n
N)
Urine Collecting Time (hour)
 CJC
 Placebo
**
**
**
**
**
*
*
*
  
Figure S.9 Adhesion forces between E. coli CFT073 and uroepithelial cells as a function of urine 
colleting time (hour) after consumption of CJC or water for volunteer 1. *Adhesion forces 
detected in urine following ingestion of CJC or placebo were significantly different. **The 
difference compared to background (pre-consumption urine) was significant.  
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Figure S.10 Adhesion forces between E. coli B37 and uroepithelial cells as a function of urine 
colleting time (hour) after consumption of CJC or water for volunteer 2. *Adhesion forces 
detected in urine following ingestion of CJC or placebo were significantly different. **The 
difference compared to background (pre-consumption urine) was significant.  
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Figure S.11 Adhesion forces between E. coli CFT073 and uroepithelial cells as a function of 
urine colleting time (hour) after consumption of CJC or water for volunteer 2. *Adhesion forces 
detected in urine following ingestion of CJC or placebo were significantly different. **The 
difference compared to background (pre-consumption urine) was significant.  
 
 
 
  
 
Appendix 
 
- 90 - 
 
 
Background 2 hours 4 hours 6 hours
0
2
4
6
8
10
12
14
16
18
20
22
24
Ad
he
sio
n 
Fo
rc
e 
(n
N)
Urine Collecting Time (hour)
 CJC
 Placebo
*
*
**
**
**
**
**
Figure S.12 Adhesion forces between E. coli B37 and uroepithelial cells as a function of urine 
colleting time (hour) after consumption of CJC or water for volunteer 3. *Adhesion forces 
detected in urine following ingestion of CJC or placebo were significantly different. **The 
difference compared to background (pre-consumption urine) was significant.  
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Figure S.13 Adhesion forces between E. coli CFT073 and uroepithelial cells as a function of 
urine colleting time (hour) after consumption of CJC or water for volunteer 3. *Adhesion forces 
detected in urine following ingestion of CJC or placebo were significantly different. **The 
difference compared to background (pre-consumption urine) was significant.  
 
 
 
 
